Browsing Bergen Open Research Archive by Author "Zhao, Huadong"
Now showing items 1-1 of 1
-
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study
Rosti, Gianantonio; Brümmendorf, Tim H.; Gjertsen, Bjørn Tore; Giraldo-Castellano, Pilar; Castagnetti, Fausto; Gambacorti-Passerini, Carlo; Ernst, Thomas; Zhao, Huadong; Kuttschreuter, Luke; Purcell, Simon; Giles, Francis J.; Hochhaus, Andreas (Journal article; Peer reviewed, 2024)In the phase 4 BYOND trial, patients with pretreated chronic myeloid leukemia (CML) received bosutinib (starting dose: 500 mg/day). Efficacy and safety after ≥3 years of follow-up in 156 patients with Philadelphia ...